GPCR · Structure Therapeutics Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-18 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Other↑
Filing footnotes — American Depositary Shares (Direct)
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. 11,817 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 3,939 American Depositary Shares. |
American Depositary Shares
|
3,939 |
| 2026-08-18 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Convert↓
Filing footnotes — Share Option (right to buy) (Direct)
Reflects price per share in Ordinary Shares. 1/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 11,817 Ordinary Shares. |
Share Option (right to buy)
|
11,817 |
| 2026-08-18 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Sell↓
Filing footnotes — American Depositary Shares (Direct)
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. Reflects price per share in American Depositary Shares. The weighted average sale price for the transaction reported was $55.05 and the range of prices were between $54.85 and $55.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. |
American Depositary Shares
|
400 |
| 2026-08-18 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Sell↓
Filing footnotes — American Depositary Shares (Direct)
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. Reflects price per share in American Depositary Shares. The weighted average sale price for the transaction reported was $53.133 and the range of prices were between $52.77 and $53.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. |
American Depositary Shares
|
3,020 |
| 2026-08-18 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
Reflects price per share in Ordinary Shares. |
Ordinary Shares
|
11,817 |
| 2026-08-18 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Other↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares were converted into American Depositary Shares as reported in Table II. |
Ordinary Shares
|
11,817 |
| 2026-08-18 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Sell↓
Filing footnotes — American Depositary Shares (Direct)
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. Reflects price per share in American Depositary Shares. The weighted average sale price for the transaction reported was $54.1970, and the range of prices were between $53.80 and $54.7950. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. |
American Depositary Shares
|
519 |
| 2026-08-06 | Berrios John Joseph |
Chief Commercial Officer |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Represents the grant of restricted share units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of August 6, 2026, subject to Reporting Person's continued service on such dates. |
Ordinary Shares
|
140,766 |
| 2026-08-06 | Berrios John Joseph |
Chief Commercial Officer |
Award↑
Filing footnotes — Share option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. One-fourth of the shares vest on the first anniversary of August 6, 2026, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. |
Share option (right to buy)
|
174,612 |
| 2026-08-04 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Sell↓
Filing footnotes — American Depositary Shares (Direct)
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. Reflects price per share in American Depositary Shares. The weighted average sale price for the transaction reported was $49.2857 and the range of prices were between $48.66 and $49.65. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. |
American Depositary Shares
|
3,100 |
| 2026-08-04 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Other↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares were converted into American Depositary Shares as reported in Table II. |
Ordinary Shares
|
11,817 |
| 2026-08-04 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Convert↓
Filing footnotes — Share Option (right to buy) (Direct)
Reflects price per share in Ordinary Shares. 1/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 11,817 Ordinary Shares. |
Share Option (right to buy)
|
11,817 |
| 2026-08-04 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Other↑
Filing footnotes — American Depositary Shares (Direct)
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. 11,817 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 3,939 American Depositary Shares. |
American Depositary Shares
|
3,939 |
| 2026-08-04 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Sell↓
Filing footnotes — American Depositary Shares (Direct)
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. Reflects price per share in American Depositary Shares. The weighted average sale price for the transaction reported was $50.0290, and the range of prices were between $49.69 and $50.33. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. |
American Depositary Shares
|
839 |
| 2026-08-04 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
Reflects price per share in Ordinary Shares. |
Ordinary Shares
|
11,817 |
| 2026-07-22 | FMR LLC |
10% Owner |
Sell↓
Filing footnotes — American Depositary Shares (Indirect)
Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $50.05 to $50.20. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information. |
American Depositary Shares
(I)
|
1,367 |
| 2026-07-22 | FMR LLC |
10% Owner |
Sell↓
Filing footnotes — American Depositary Shares (Indirect)
Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $50.05 to $50.20. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information. |
American Depositary Shares
(I)
|
16,085 |
| 2026-07-14 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Other↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares were converted into American Depositary Shares as reported in Table II. |
Ordinary Shares
|
23,634 |
| 2026-07-14 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Other↑
Filing footnotes — American Depositary Shares (Direct)
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. 23,634 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 7,878 American Depositary Shares. |
American Depositary Shares
|
7,878 |
| 2026-07-14 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Sell↓
Filing footnotes — American Depositary Shares (Direct)
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. Reflects price per share in American Depositary Shares. The weighted average sale price for the transaction reported was $50.7956 and the range of prices were between $50.31 and $51.30. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. |
American Depositary Shares
|
6,278 |
| 2026-07-14 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
Reflects price per share in Ordinary Shares. |
Ordinary Shares
|
23,634 |
| 2026-07-14 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Convert↓
Filing footnotes — Share Option (right to buy) (Direct)
Reflects price per share in Ordinary Shares. 1/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 23,634 Ordinary Shares. |
Share Option (right to buy)
|
23,634 |
| 2026-07-14 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Sell↓
Filing footnotes — American Depositary Shares (Direct)
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. Reflects price per share in American Depositary Shares. The weighted average sale price for the transaction reported was $51.7088, and the range of prices were between $51.32 and $52.27. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. |
American Depositary Shares
|
1,600 |
| 2026-06-25 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Other↑
Filing footnotes — American Depositary Shares (Direct)
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. 23,634 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 7,878 American Depositary Shares. |
American Depositary Shares
|
7,878 |
| 2026-06-25 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
Reflects price per share in Ordinary Shares. |
Ordinary Shares
|
23,634 |
| 2026-06-25 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Convert↓
Filing footnotes — Share Option (right to buy) (Direct)
Reflects price per share in Ordinary Shares. 1/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 23,634 Ordinary Shares. |
Share Option (right to buy)
|
23,634 |
| 2026-06-25 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Other↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares were converted into American Depositary Shares as reported in Table II. |
Ordinary Shares
|
23,634 |
| 2026-06-25 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Sell↓
Filing footnotes — American Depositary Shares (Direct)
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. Reflects price per share in American Depositary Shares. |
American Depositary Shares
|
7,878 |
| 2026-06-17 | Russell Angus C. |
Director |
Award↑
Filing footnotes — Share Option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting, The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. |
Share Option (right to buy)
|
39,453 |
| 2026-06-17 | Waldstreicher Joanne |
Director |
Award↑
Filing footnotes — Share Option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting, The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. |
Share Option (right to buy)
|
39,453 |
| 2026-06-17 | WELCH DANIEL G |
Director |
Award↑
Filing footnotes — Share Option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting, The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. |
Share Option (right to buy)
|
39,453 |
| 2026-06-17 | LOVE TED W |
Director |
Award↑
Filing footnotes — Share Option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting, The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. |
Share Option (right to buy)
|
39,453 |
| 2026-06-17 | DOBMEIER ERIC |
Director |
Award↑
Filing footnotes — Share Option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting, The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. |
Share Option (right to buy)
|
39,453 |
| 2026-06-17 | TETLOW SHARON |
Director |
Award↑
Filing footnotes — Share Option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting, The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. |
Share Option (right to buy)
|
39,453 |
| 2026-04-15 | Lang Matthew |
Chief Business Officer |
Award↑
Filing footnotes — Share option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. One-fourth of the shares vest on the first anniversary of April 15, 2026, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. |
Share option (right to buy)
|
223,776 |
| 2026-04-15 | Lang Matthew |
Chief Business Officer |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of April 15, 2026, subject to Reporting Person's continued service on such dates. |
Ordinary Shares
|
184,614 |
| 2026-04-14 | FMR LLC |
10% Owner |
Sell↓
Filing footnotes — American Depositary Shares (Indirect)
Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $55.00 to $55.20. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information. |
American Depositary Shares
(I)
|
1,367 |
| 2026-04-14 | FMR LLC |
10% Owner |
Sell↓
Filing footnotes — American Depositary Shares (Indirect)
Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $55.00 to $55.20. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information. |
American Depositary Shares
(I)
|
16,085 |
| 2026-03-19 | Stevens Raymond C |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. |
Employee Stock Option (right to buy)
|
322,230 |
| 2026-03-19 | Yoon Jun |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. |
Employee Stock Option (right to buy)
|
128,892 |
| 2026-03-19 | Stevens Raymond C |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates. |
Ordinary Shares
|
260,217 |
| 2026-03-19 | Coll Crespo Blas |
CHIEF MEDICAL OFFICER |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates. |
Ordinary Shares
|
75,897 |
| 2026-03-19 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates. |
Ordinary Shares
|
43,368 |
| 2026-03-19 | Coll Crespo Blas |
CHIEF MEDICAL OFFICER |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. |
Employee Stock Option (right to buy)
|
93,984 |
| 2026-03-19 | Lin Xichen |
CHIEF SCIENTIFIC OFFICER |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. |
Employee Stock Option (right to buy)
|
53,703 |
| 2026-03-19 | Yoon Jun |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates. |
Ordinary Shares
|
104,085 |
| 2026-03-19 | Hall Ashley |
Chief Development Officer |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates. |
Ordinary Shares
|
47,706 |
| 2026-03-19 | Ma Yingli |
CHIEF TECHNOLOGY OFFICER |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates. |
Ordinary Shares
|
32,526 |
| 2026-03-19 | Hall Ashley |
Chief Development Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. |
Employee Stock Option (right to buy)
|
59,073 |
| 2026-03-19 | Ma Yingli |
CHIEF TECHNOLOGY OFFICER |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. |
Employee Stock Option (right to buy)
|
40,278 |